(+)-schisandrin B multiple interactions ISO RGD:1562307 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SPSB4 mRNA] CTD PMID:31150632 1,2-dichloroethane affects expression EXP 6480464 ethylene dichloride affects the expression of SPSB4 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression ISO RGD:1562307 6480464 1-Naphthylisothiocyanate results in increased expression of SPSB4 mRNA CTD PMID:25380136 , PMID:30723492 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1562307 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SPSB4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1562307 6480464 Tetrachlorodibenzodioxin affects the expression of SPSB4 mRNA CTD PMID:32109520 4,4'-diaminodiphenylmethane increases expression ISO RGD:1562307 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SPSB4 mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SPSB4 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of SPSB4 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO RGD:1562307 6480464 Propylthiouracil results in increased expression of SPSB4 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:1562307 6480464 acetamide results in increased expression of SPSB4 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1562307 6480464 Acrylamide results in decreased expression of SPSB4 mRNA CTD PMID:28959563 all-trans-retinoic acid increases expression ISO RGD:1562307 6480464 Tretinoin results in increased expression of SPSB4 mRNA CTD PMID:20488242 antirheumatic drug increases expression ISO RGD:1603370 6480464 Antirheumatic Agents results in increased expression of SPSB4 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1603370 6480464 Arsenic affects the methylation of SPSB4 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1603370 6480464 Arsenic affects the methylation of SPSB4 gene CTD PMID:25304211 arsenite(3-) increases methylation ISO RGD:1603370 6480464 arsenite results in increased methylation of SPSB4 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of SPSB4 mRNA CTD PMID:19770486 , PMID:27195522 benzo[a]pyrene increases methylation ISO RGD:1603370 6480464 Benzoapyrene results in increased methylation of SPSB4 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1603370 6480464 Benzoapyrene affects the methylation of SPSB4 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1603370 6480464 Benzoapyrene results in decreased methylation of SPSB4 3' UTR CTD PMID:27901495 bisphenol A affects expression ISO RGD:1562307 6480464 bisphenol A affects the expression of SPSB4 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A increases methylation ISO RGD:1562307 6480464 bisphenol A results in increased methylation of SPSB4 gene CTD PMID:28505145 bromobenzene increases expression ISO RGD:1562307 6480464 bromobenzene results in increased expression of SPSB4 mRNA CTD PMID:32479839 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of SPSB4 mRNA CTD PMID:29038090 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of SPSB4 mRNA CTD PMID:25554681 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPSB4 gene CTD PMID:20938992 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of SPSB4 mRNA CTD PMID:18353800 decabromodiphenyl ether decreases expression ISO RGD:1562307 6480464 decabromobiphenyl ether results in decreased expression of SPSB4 mRNA CTD PMID:23640034 decabromodiphenyl ether increases expression ISO RGD:1562307 6480464 decabromobiphenyl ether results in increased expression of SPSB4 mRNA CTD PMID:23640034 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SPSB4 mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of SPSB4 mRNA CTD PMID:28962523 dorsomorphin multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1603370 6480464 Doxorubicin results in decreased expression of SPSB4 mRNA CTD PMID:29803840 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPSB4 gene CTD PMID:20938992 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of SPSB4 mRNA CTD PMID:25629700 furan increases expression ISO RGD:1562307 6480464 furan results in increased expression of SPSB4 mRNA CTD PMID:25539665 glafenine increases expression ISO RGD:1562307 6480464 Glafenine results in increased expression of SPSB4 mRNA CTD PMID:24136188 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPSB4 gene CTD PMID:20938992 mercury dibromide increases expression ISO RGD:1603370 6480464 mercuric bromide results in increased expression of SPSB4 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SPSB4 mRNA CTD PMID:27188386 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SPSB4 mRNA] CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SPSB4 mRNA CTD PMID:25566086 N-nitrosodimethylamine increases expression ISO RGD:1562307 6480464 Dimethylnitrosamine results in increased expression of SPSB4 mRNA CTD PMID:25380136 panobinostat multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SPSB4 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1603370 6480464 panobinostat results in increased expression of SPSB4 mRNA CTD PMID:26272509 paracetamol increases expression ISO RGD:1562307 6480464 Acetaminophen results in increased expression of SPSB4 mRNA CTD PMID:32479839 phenylmercury acetate increases expression ISO RGD:1603370 6480464 Phenylmercuric Acetate results in increased expression of SPSB4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SPSB4 mRNA CTD PMID:27188386 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SPSB4 mRNA CTD PMID:18301758 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SPSB4 mRNA CTD PMID:20813756 more ... pirinixic acid multiple interactions EXP 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of SPSB4 mRNA] CTD PMID:21318169 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of SPSB4 mRNA CTD PMID:23608068 resveratrol multiple interactions ISO RGD:1562307 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SPSB4 mRNA CTD PMID:25905778 SB 431542 multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SPSB4 mRNA CTD PMID:23221170 streptozocin multiple interactions ISO RGD:1562307 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SPSB4 mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:1603370 6480464 Sunitinib results in decreased expression of SPSB4 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of SPSB4 mRNA CTD PMID:20937368 testosterone increases expression EXP 6480464 Testosterone results in increased expression of SPSB4 mRNA CTD PMID:21669218 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SPSB4 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1562307 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SPSB4 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1562307 6480464 Carbon Tetrachloride results in decreased expression of SPSB4 mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SPSB4 mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide increases expression ISO RGD:1562307 6480464 Thioacetamide results in increased expression of SPSB4 mRNA CTD PMID:23411599 trichloroethene increases methylation ISO RGD:1562307 6480464 Trichloroethylene results in increased methylation of SPSB4 gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1603370 6480464 trichostatin A results in increased expression of SPSB4 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SPSB4 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SPSB4 mRNA CTD PMID:21427059 valproic acid multiple interactions ISO RGD:1603370 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of SPSB4 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1603370 6480464 Valproic Acid results in increased expression of SPSB4 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1603370 6480464 Valproic Acid results in decreased methylation of SPSB4 gene CTD PMID:29154799 vancomycin increases expression EXP 6480464 Vancomycin results in increased expression of SPSB4 mRNA CTD PMID:18930951